Adverse effects in children and adolescents with ADHD receiving 6 weeks of daily atomoxetine or placebo
| Atomoxetine % (n=85) | Placebo % (n=85) | Number needed to treat with atomoxetine to harm 1 person (95% CI) | Absolute risk increase % (95% CI) | |
|---|---|---|---|---|
| Decreased appetite | 20.0 | 5.9 | 7 (4 to 24) | 14.1 (4.2 to 24.0) |
| Vomiting | 15.3 | 1.2 | 7 (5 to 16) | 14.1 (6.1 to 22.1) |
| Nausea | 11.8 | 2.4 | 11 (6 to 55) | 9.4 (1.8 to 17.0) |
| Asthenia | 10.6 | 1.2 | 11 (6 to 41) | 9.4 (2.5 to 16.3) |
| Dyspepsia | 9.4 | 0.0 | 11 (6 to 31) | 9.4 (3.2 to 15.6) |
CiteULike
Connotea
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
Technorati
TwitterDon't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Online ISSN 1468-960X
Copyright © 2012 by the BMJ Publishing Group Ltd, Royal College of Psychiatrists & British Psychological Society
